• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

比较体外和体内来源的 Tau 纤维中大小分布和(Pro249-Ser258)表位暴露情况。

Comparison of size distribution and (Pro249-Ser258) epitope exposure in in vitro and in vivo derived Tau fibrils.

机构信息

Neuroscience department, Janssen Pharmaceutical Companies of Johnson and Johnson, 2340, Beerse, Belgium.

Animal Physiology and Neurobiology, KU Leuven, Naamsestraat 59, 3000, Leuven, Belgium.

出版信息

BMC Mol Cell Biol. 2020 Nov 12;21(1):81. doi: 10.1186/s12860-020-00320-y.

DOI:10.1186/s12860-020-00320-y
PMID:33183222
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7661158/
Abstract

BACKGROUND

Although several studies demonstrate prion-like properties of Tau fibrils, the effect of size in the seeding capacity of these aggregates is not fully understood. The aim of this study is to characterize Tau seeds by their size and seeding capacity.

METHODS

Tau aggregates were isolated from postmortem AD brain tissue and separated from low molecular weight species by sucrose gradient ultracentrifugation. Biochemical characterization of the different fractions was done by non-reducing Western blotting and aggregate-specific immuno-assays using in house developed anti-Tau monoclonal antibodies, including PT76 which binds to an epitope close to the microtubule-binding domain and, hence, also to K18. Seeding efficiency was then assessed in HEK293 cells expressing K18 FRET sensors.

RESULTS

We observed that upon sonication of Tau aggregates different size-distributed tau aggregates are obtained. In biochemical assays, these forms show higher signals than the non-sonicated material in some aggregation-specific Tau assays. This could be explained by an increased epitope exposure of the smaller aggregates created by the sonication. By analyzing human brain derived and recombinant (K18) Tau aggregates in a cellular FRET assay, it was observed that, in the absence of transfection reagent, sonicated aggregates showed higher aggregation induction. Preparations also showed altered profiles on native PAGE upon sonication and we could further separate different aggregate species based on their molecular weight via sucrose gradients.

CONCLUSIONS

This study further elucidates the molecular properties regarding relative aggregate size and seeding efficiency of sonicated vs. non-sonicated high molecular weight Tau species. This information will provide a better knowledge on how sonication, a commonly used technique in the field of study of Tau aggregation, impacts the aggregates. In addition, the description of PT76-based aggregation specific assay is a valuable tool to quantify K18 and human AD Tau fibrils.

摘要

背景

尽管有几项研究表明 Tau 纤维具有类朊病毒特性,但这些聚集物的大小对其接种能力的影响尚未完全阐明。本研究旨在通过其大小和接种能力来表征 Tau 种子。

方法

从尸检 AD 脑组织中分离 Tau 聚集物,并通过蔗糖梯度超速离心将其与低分子量物质分离。使用内部开发的抗 Tau 单克隆抗体,包括与微管结合域附近的表位结合,因此也与 K18 结合的 PT76,通过非还原 Western blot 和聚集物特异性免疫测定对不同级分进行生化特性分析。然后在表达 K18 FRET 传感器的 HEK293 细胞中评估接种效率。

结果

我们观察到,在 Tau 聚集物的超声处理后,会得到不同大小分布的 Tau 聚集物。在生化测定中,与非超声处理材料相比,这些形式在某些聚集物特异性 Tau 测定中显示出更高的信号。这可以通过超声处理产生的较小聚集物的表位暴露增加来解释。通过在细胞 FRET 测定中分析源自人脑中的和重组的(K18)Tau 聚集物,观察到在没有转染试剂的情况下,超声处理的聚集物显示出更高的聚集诱导。超声处理后,天然 PAGE 上的制备物也显示出改变的图谱,我们还可以通过蔗糖梯度根据分子量进一步分离不同的聚集物物种。

结论

本研究进一步阐明了与超声处理的高分子量 Tau 物种的相对聚集物大小和接种效率相关的分子特性。这些信息将提供关于超声处理对聚集物的影响的更好的知识。此外,基于 PT76 的聚集特异性测定的描述是量化 K18 和人 AD Tau 纤维的有价值的工具。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/20eb/7661158/f4679b4d882a/12860_2020_320_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/20eb/7661158/ccf7363a1a72/12860_2020_320_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/20eb/7661158/6def1fd6ebf4/12860_2020_320_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/20eb/7661158/8e81a9000da9/12860_2020_320_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/20eb/7661158/9a22998eb7e1/12860_2020_320_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/20eb/7661158/b28976fcb394/12860_2020_320_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/20eb/7661158/f4679b4d882a/12860_2020_320_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/20eb/7661158/ccf7363a1a72/12860_2020_320_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/20eb/7661158/6def1fd6ebf4/12860_2020_320_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/20eb/7661158/8e81a9000da9/12860_2020_320_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/20eb/7661158/9a22998eb7e1/12860_2020_320_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/20eb/7661158/b28976fcb394/12860_2020_320_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/20eb/7661158/f4679b4d882a/12860_2020_320_Fig6_HTML.jpg

相似文献

1
Comparison of size distribution and (Pro249-Ser258) epitope exposure in in vitro and in vivo derived Tau fibrils.比较体外和体内来源的 Tau 纤维中大小分布和(Pro249-Ser258)表位暴露情况。
BMC Mol Cell Biol. 2020 Nov 12;21(1):81. doi: 10.1186/s12860-020-00320-y.
2
Amyloidogenic cross-seeding of Tau protein: Transient emergence of structural variants of fibrils.Tau 蛋白的淀粉样纤维交叉成核:纤维结构变体的瞬时出现。
PLoS One. 2018 Jul 19;13(7):e0201182. doi: 10.1371/journal.pone.0201182. eCollection 2018.
3
Conformation determines the seeding potencies of native and recombinant Tau aggregates.构象决定天然和重组 Tau 聚集体的种子形成能力。
J Biol Chem. 2015 Jan 9;290(2):1049-65. doi: 10.1074/jbc.M114.589309. Epub 2014 Nov 18.
4
Structure-based inhibitors halt prion-like seeding by Alzheimer's disease-and tauopathy-derived brain tissue samples.基于结构的抑制剂阻止了阿尔茨海默病和 tau 病源性脑组织样本中的朊病毒样种子的形成。
J Biol Chem. 2019 Nov 1;294(44):16451-16464. doi: 10.1074/jbc.RA119.009688. Epub 2019 Sep 19.
5
Cellular Models of Aggregation-dependent Template-directed Proteolysis to Characterize Tau Aggregation Inhibitors for Treatment of Alzheimer Disease.用于表征治疗阿尔茨海默病的tau聚集抑制剂的聚集依赖性模板导向蛋白水解的细胞模型
J Biol Chem. 2015 Apr 24;290(17):10862-75. doi: 10.1074/jbc.M114.616029. Epub 2015 Mar 10.
6
Tau protein liquid-liquid phase separation can initiate tau aggregation.tau 蛋白液-液相分离可引发 tau 聚集。
EMBO J. 2018 Apr 3;37(7). doi: 10.15252/embj.201798049. Epub 2018 Feb 22.
7
GFP-Mutant Human Tau Transgenic Mice Develop Tauopathy Following CNS Injections of Alzheimer's Brain-Derived Pathological Tau or Synthetic Mutant Human Tau Fibrils.在向中枢神经系统注射阿尔茨海默病脑源性病理性tau蛋白或合成突变型人tau蛋白原纤维后,绿色荧光蛋白标记的突变型人tau转基因小鼠出现tau蛋白病。
J Neurosci. 2017 Nov 22;37(47):11485-11494. doi: 10.1523/JNEUROSCI.2393-17.2017. Epub 2017 Oct 6.
8
Prevention of tau seeding and propagation by immunotherapy with a central tau epitope antibody.通过针对中心tau 表位的抗体免疫疗法预防 tau 种子和传播。
Brain. 2019 Jun 1;142(6):1736-1750. doi: 10.1093/brain/awz100.
9
Effects of tau domain-specific antibodies and intravenous immunoglobulin on tau aggregation and aggregate degradation.tau结构域特异性抗体和静脉注射免疫球蛋白对tau聚集及聚集体降解的影响
Biochemistry. 2015 Jan 20;54(2):293-302. doi: 10.1021/bi501272x. Epub 2015 Jan 6.
10
Alzheimer's disease seeded tau forms paired helical filaments yet lacks seeding potential.阿尔茨海默病的 tau 形成 seeded 双螺旋丝,但缺乏 seeding 潜能。
J Biol Chem. 2024 Sep;300(9):107730. doi: 10.1016/j.jbc.2024.107730. Epub 2024 Aug 28.

引用本文的文献

1
The 3-O sulfation of heparan sulfate proteoglycans contributes to the cellular internalization of tau aggregates.硫酸乙酰肝素蛋白聚糖 3-O 位的硫酸化有助于 tau 聚集物的细胞内化。
BMC Mol Cell Biol. 2022 Dec 24;23(1):61. doi: 10.1186/s12860-022-00462-1.
2
Quantitative super-resolution imaging of pathological aggregates reveals distinct toxicity profiles in different synucleinopathies.定量超分辨率成像病理性聚集体揭示不同神经核蛋白病的不同毒性特征。
Proc Natl Acad Sci U S A. 2022 Oct 11;119(41):e2205591119. doi: 10.1073/pnas.2205591119. Epub 2022 Oct 7.

本文引用的文献

1
Transmission of tauopathy strains is independent of their isoform composition.tau 病株的传播与其异构体组成无关。
Nat Commun. 2020 Jan 7;11(1):7. doi: 10.1038/s41467-019-13787-x.
2
Heparin-induced tau filaments are polymorphic and differ from those in Alzheimer's and Pick's diseases.肝素诱导的 tau 丝是多态的,与阿尔茨海默病和匹克病中的 tau 丝不同。
Elife. 2019 Feb 5;8:e43584. doi: 10.7554/eLife.43584.
3
In Vitro Assay for Studying the Aggregation of Tau Protein and Drug Screening.用于研究 Tau 蛋白聚集及药物筛选的体外测定法
J Vis Exp. 2018 Nov 20(141). doi: 10.3791/58570.
4
Soluble tau aggregates, not large fibrils, are the toxic species that display seeding and cross-seeding behavior.可溶性 tau 聚集体,而不是大纤维,是具有种子和交叉播种行为的毒性物质。
Protein Sci. 2018 Nov;27(11):1901-1909. doi: 10.1002/pro.3499. Epub 2018 Oct 19.
5
Anti-Tau Monoclonal Antibodies Derived from Soluble and Filamentous Tau Show Diverse Functional Properties in vitro and in vivo.抗 Tau 单克隆抗体来源于可溶性和丝状 Tau,在体外和体内显示出不同的功能特性。
J Alzheimers Dis. 2018;65(1):265-281. doi: 10.3233/JAD-180404.
6
Inert and seed-competent tau monomers suggest structural origins of aggregation.无定型和有种子能力的 tau 单体提示了聚集的结构起源。
Elife. 2018 Jul 10;7:e36584. doi: 10.7554/eLife.36584.
7
Cryo-EM structures of tau filaments from Alzheimer's disease.阿尔茨海默病tau蛋白细丝的冷冻电镜结构
Nature. 2017 Jul 13;547(7662):185-190. doi: 10.1038/nature23002. Epub 2017 Jul 5.
8
Protein misfolding in neurodegenerative diseases: implications and strategies.神经退行性疾病中的蛋白质错误折叠:影响与策略
Transl Neurodegener. 2017 Mar 13;6:6. doi: 10.1186/s40035-017-0077-5. eCollection 2017.
9
Tau Prion Strains Dictate Patterns of Cell Pathology, Progression Rate, and Regional Vulnerability In Vivo.tau蛋白朊病毒株决定体内细胞病理学模式、进展速率和区域易损性
Neuron. 2016 Nov 23;92(4):796-812. doi: 10.1016/j.neuron.2016.09.055. Epub 2016 Oct 27.
10
Unique pathological tau conformers from Alzheimer's brains transmit tau pathology in nontransgenic mice.来自阿尔茨海默病大脑的独特病理性tau构象在非转基因小鼠中传播tau病理。
J Exp Med. 2016 Nov 14;213(12):2635-2654. doi: 10.1084/jem.20160833. Epub 2016 Oct 17.